UK markets closed
NIKKEI 225
38,274.05 -131.61 (-0.34%) HANG SENG
17,763.03 +16.12 (+0.09%) CRUDE OIL
79.05 -2.88 (-3.52%) GOLD FUTURES
2,310.10 +7.20 (+0.31%) DOW
37,970.82 +154.90 (+0.41%) Bitcoin GBP
45,986.76 -2,302.55 (-4.77%)
ReShape Lifesciences Inc. (RSLS)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
As of 01:56PM EDT. Market open.
Currency in USD
Valuation measures4
| Market cap (intra-day) | 3.89M |
| Enterprise value | -303.12k |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 0.11 |
| Price/book (mrq) | 0.58 |
| Enterprise value/revenue | -0.03 |
| Enterprise value/EBITDA | 0.02 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.30 |
| 52-week change 3 | -93.33% |
| S&P500 52-week change 3 | 23.10% |
| 52-week high 3 | 2.7980 |
| 52-week low 3 | 0.1410 |
| 50-day moving average 3 | 0.1686 |
| 200-day moving average 3 | 0.4481 |
Share statistics
| Avg vol (3-month) 3 | 494.26k |
| Avg vol (10-day) 3 | 204.78k |
| Shares outstanding 5 | 23.46M |
| Implied shares outstanding 6 | 23.46M |
| Float 8 | 20.82M |
| % held by insiders 1 | 11.16% |
| % held by institutions 1 | 1.97% |
| Shares short (15 Apr 2024) 4 | 487.78k |
| Short ratio (15 Apr 2024) 4 | 1.18 |
| Short % of float (15 Apr 2024) 4 | 2.33% |
| Short % of shares outstanding (15 Apr 2024) 4 | 2.08% |
| Shares short (prior month 15 Mar 2024) 4 | 428.69k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | 25 Jul 2019 |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:50 |
| Last split date 3 | 23 Dec 2022 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | -131.22% |
| Operating margin (ttm) | -95.61% |
Management effectiveness
| Return on assets (ttm) | -83.92% |
| Return on equity (ttm) | -220.59% |
Income statement
| Revenue (ttm) | 8.68M |
| Revenue per share (ttm) | 1.46 |
| Quarterly revenue growth (yoy) | -36.30% |
| Gross profit (ttm) | N/A |
| EBITDA | -14.48M |
| Net income avi to common (ttm) | -11.39M |
| Diluted EPS (ttm) | -1.9100 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 4.46M |
| Total cash per share (mrq) | 0.19 |
| Total debt (mrq) | 262k |
| Total debt/equity (mrq) | 3.93% |
| Current ratio (mrq) | 2.73 |
| Book value per share (mrq) | 0.28 |
Cash flow statement
| Operating cash flow (ttm) | -16.96M |
| Levered free cash flow (ttm) | -11.7M |
© 2024 Yahoo. All rights reserved.